Workflow
医疗服务
icon
Search documents
胸部微创手术进入“无管化”新时代
Qi Lu Wan Bao· 2026-01-16 11:05
"别人做手术是被推出手术室,我是自己走出来的。而且,这才第三天,大夫就已经安排我出院了!"日前,在 德州市第二人民医院胸外科病房内,51岁的孙女士(化名)正微笑着与病友们分享自己的手术经历。 不久后,手术如期进行。术中,在麻醉医生的帮助下,患者仅通过一个喉罩维持呼吸,体表再无任何插管。张 瑞带领团队通过单孔胸腔镜技术,精准切除了患者右肺上的肿块。麻醉苏醒后,孙女士并未感受到预想中 的剧烈疼痛和不适。更令她惊讶的是,在医护人员的陪同下,她竟然自己就走出了手术间!"当时在手术室 外等候的家人都看呆了,说从没见过谁做完胸部手术还能自己走着出来的。"回忆当时的情景,孙女士脸上 洋溢着笑容。 "Tubeless快速康复技术的核心在于'无管化',最大限度减少手术对患者生理的干扰,降低术后疼痛和并发 症风险,缩短康复时间,从而让患者从'害怕手术'转变为'安心手术'。"张瑞介绍。今后,德州市第二人民医 院胸外科将继续深耕微创技术与快速康复理念,为更多患者提供更先进、优质、高效以及人性化的诊疗 服务。 在知晓了孙女士的担忧后,张瑞仔细查看了她的各项检查报告,并结合其身体状况与病情,带领团队为她量 身制定了"单孔胸腔镜联合tub ...
今年丰台将推动32家门诊向适龄女生免费接种HPV疫苗
Xin Jing Bao· 2026-01-16 11:04
在医疗领域,今年丰台区将有一批民生举措落地。丰台康复医院、丰台区心理卫生中心将于年内开工, 丰台中西医结合医院二期项目主体结构也将封顶。 今年,丰台区将打造1个国家级、3个市级水平临床重点专科,建设10个"智慧家医"巡诊点,深化6个紧 密型城市医疗集团建设,打造4个慢性病管理中心试点。 新京报讯(记者姜慧梓)记者从1月16日举行的北京市丰台区"两会"系列发布活动上获悉,今年丰台区将 推动32家接种门诊全面提供适龄女生HPV疫苗免费接种服务。 展望"十五五",力争到2030年实现丰台全区居民健康素养水平提升至50%以上。打造生育友好型城区, 落实国家育儿补贴政策,建设3家生育友好医院、2家儿童友好医院,显著提升妇女儿童健康服务获得 感;推动23家区直属医疗机构全面应用AI智能辅助诊断。 ...
龙虎榜 | 机构狂抛佰维存储近13亿!深南东路、章盟主爆买美年健康
Ge Long Hui A P P· 2026-01-16 10:40
Market Overview - The A-share market experienced a downward trend with a total trading volume of 3.06 trillion yuan, an increase of 118 billion yuan compared to the previous trading day [1] - The AI application sector faced a significant decline for the second consecutive day, with Sora concept, Kimi concept, Zhipu AI, and AI corpus leading the losses [1] Sector Performance - The semiconductor sector surged, with storage chips, silicon carbide, and automotive chips leading the gains, while industrial gases, ultra-high voltage, and industrial mother machines also showed strong performance [2] - A total of 58 stocks hit the daily limit up, with 6 stocks on consecutive limit up, and 39 stocks failed to close at the limit, resulting in a limit-up rate of 60% (excluding ST and delisted stocks) [4] Focus Stocks - In the smart grid sector, Bofei Electric achieved 6 consecutive limit ups over 9 days, while Xinhua Department Store and Debang Co., Ltd. both recorded 3 consecutive limit ups due to stock transfer and voluntary delisting, respectively [5][6] - Notable stocks included: - Bofei Electric: Price 55.21 yuan, +10.00%, 5 consecutive limit ups [6] - Debang Co., Ltd.: Price 18.68 yuan, +10.01%, 3 consecutive limit ups [6] - Xinhua Free Trade: Price 18.82 yuan, +9.99%, 3 consecutive limit ups [6] Trading Dynamics - The top three net buying stocks on the Dragon and Tiger list were Meinian Health, Sanan Optoelectronics, and Tongyu Communication, with net purchases of 579 million yuan, 552 million yuan, and 346 million yuan, respectively [7] - The top three net selling stocks were Baiwei Storage, Aerospace Electromechanical, and Shenglu Communication, with net sales of 574 million yuan, 501 million yuan, and 499 million yuan, respectively [9] Institutional Activity - Among stocks with institutional trading, the highest net buying was seen in Snowman Group, Tongyu Communication, and Hongxiang Co., Ltd., with net purchases of 234 million yuan, 211 million yuan, and 202 million yuan, respectively [10] - Conversely, Baiwei Storage, Siyuan Electric, and Tongfu Microelectronics had the highest net selling amounts, totaling 1.295 billion yuan, 292 million yuan, and 86.78 million yuan, respectively [11] Notable Stock Movements - Meinian Health saw a significant drop of 9.99% after a previous 5-day cumulative increase of 52.78%, leading to profit-taking [12] - Sanan Optoelectronics reported a 10.04% increase, driven by strong quarterly earnings and capital expenditure plans [15] - Tongyu Communication faced an 8.75% decline, attributed to a recent adjustment in the commercial aerospace sector despite a substantial cumulative increase of 256.08% since late November [18] Company Earnings Forecasts - Baiwei Storage projected a net profit of 850-1,000 million yuan for 2025, representing a year-on-year growth of 427%-520%, with a significant quarterly increase expected [20]
广西推动优质医疗资源扩容下沉 惠及更多民众
Zhong Guo Xin Wen Wang· 2026-01-16 10:39
Core Viewpoint - Guangxi is enhancing the support and expansion of quality medical resources to benefit more citizens through the "Intelligent Gathering of Eight桂·Famous Doctors Training" initiative [1][2]. Group 1: Initiative Overview - The "Intelligent Gathering of Eight桂·Famous Doctors Training" initiative aims to address the shortage of quality medical resources and high-level talent by establishing famous doctor workstations in key medical institutions [2]. - The initiative focuses on flexible recruitment of high-level medical expert teams to improve local healthcare services [2]. Group 2: Event Highlights - The Guangxi Medical University Affiliated Wuming Hospital held a high-quality development conference showcasing achievements in hospital construction, talent cultivation, and clinical education innovation [2]. - The establishment of the famous doctor workstation and the "Changjiang Scholar" Professor Wang Tao's studio was announced during the event, aiming to enhance service capabilities and create replicable experiences [5]. Group 3: Future Plans - The Guangxi Medical University plans to leverage the workstation platform to strengthen its academic specialties and accelerate clinical research and results transformation [5]. - The Wuming Hospital aims to build a collaborative system with top expert teams, focusing on talent cultivation and technical breakthroughs to enhance regional healthcare levels [7].
该不该将AI引入电子病历,张文宏提出了一个问题
Xin Jing Bao· 2026-01-16 09:48
据《南方都市报》报道,因"拒绝将AI引入其所在医院的电子病历系统"的发言,近日,国家传染病医学 中心主任张文宏引发热议。张文宏表示,若将AI引入病历系统,会改变现有的年轻医生培养体系。 不难预见,如果AI介入了诸如病历书写这样的基础工作,医生在一般性工作中的锻炼和经验积累的机 会会减少,但这在某种程度上其实是不可避免的。 因为在科技的推动下,人类的很多能力都在不断退化。正如前文提到的,现在的法医都在用AI识别指 纹,个人识别指纹的能力在下降。可以想象,如果AI可以轻松识别肺里的小结节,那么医生在这方面 的能力也会下降。 不只是医学,在方方面面我们都面临着"AI让人的能力退化"的情况。例如,随着技术的进步,不少司机 在识别道路的能力方面,就在逐步退步。而且,如果关闭倒车影像,当下的不少司机甚至不敢倒车,而 这在过去可是汽车司机的必备技能。 不过,张文宏并不是全盘拒绝AI。他表示,自己也会使用AI,他接触的病人量太大、太复杂,短期内 处理大量病人时,一般会让AI"先看一遍","但是我一般看一眼就知道(AI)哪里是错的",而年轻医生 则有可能被误导。他强调,是否会被误导,取决于"你的能力是不是强过这个AI"。 AI ...
价值700亿美元的AI+医疗仍有很长的路要走丨ToB产业观察
Tai Mei Ti A P P· 2026-01-16 09:38
Core Insights - The Chinese government has officially launched the "Artificial Intelligence +" initiative, focusing on enhancing the healthcare sector through AI applications, aiming to improve the quality of life and healthcare services [2] - The healthcare industry is becoming a primary area for AI technology implementation, transitioning from optional to essential applications, with significant growth expected in the AI healthcare market [2][3] Industry Overview - The healthcare sector faces critical challenges such as uneven resource distribution, high physician workloads, and low research translation efficiency, creating ample opportunities for AI applications [3] - By 2025, the global AI application market is projected to reach $127 billion, with the healthcare sector accounting for 20% of this total [2] - The "AI + healthcare" market is expected to grow at a compound annual growth rate of over 29%, reaching $70 billion by 2032 [2] AI Applications in Healthcare - AI applications in healthcare have evolved through various stages, with clinical decision support systems (CDSS) being a key area of focus, addressing the knowledge gap between medical advancements and physician expertise [3][4] - The introduction of large language models has significantly improved the capabilities of CDSS, allowing for real-time updates and broader disease coverage, with accuracy rates surpassing 91% in some cases [5][11] - Medical imaging AI has matured, transitioning from basic disease screening to advanced multi-modal analysis, enhancing diagnostic precision and patient outcomes [6][7] Business Models and Commercialization - The commercialization of medical imaging AI is shifting from product sales to service-based models, driven by the integration of AI into healthcare workflows [7][10] - Companies like Ping An are leveraging AI to enhance patient services, streamline processes, and improve healthcare accessibility, with AI assisting in over 50% of family doctor tasks [8][11] - The AI healthcare market is facing challenges related to high development costs, long return on investment periods, and difficulties in monetization due to varying payment capabilities across healthcare institutions [21][22] Challenges and Future Outlook - Despite advancements, the integration of AI in healthcare faces hurdles such as data quality, regulatory issues, and the need for explainability in AI decision-making [16][19] - The lack of standardized, high-quality data across healthcare institutions hampers the training of AI models, necessitating improvements in data governance and sharing mechanisms [18][19] - The AI + healthcare sector is expected to enter a new phase of large-scale implementation by 2026, driven by collaborative efforts and continuous technological innovation [22]
医疗服务板块1月16日跌2.51%,迪安诊断领跌,主力资金净流出25.83亿元
Core Viewpoint - The medical services sector experienced a decline of 2.51% on January 16, with Dean Diagnostics leading the drop. The Shanghai Composite Index closed at 4101.91, down 0.26%, while the Shenzhen Component Index closed at 14281.08, down 0.18% [1]. Group 1: Stock Performance - Dean Diagnostics (300244) saw a significant drop of 12.86%, closing at 25.27, with a trading volume of 1.061 million shares and a transaction value of 2.816 billion [2]. - Other notable declines included Hongbo Pharmaceutical (301230) down 11.61% to 46.50, and New Mileage (002219) down 10.00% to 2.34 [2]. - Conversely, Jin Kai Sheng Song (301509) increased by 2.15% to 38.43, with a transaction value of 196 million [1]. Group 2: Capital Flow - The medical services sector experienced a net outflow of 2.583 billion from institutional investors, while retail investors saw a net inflow of 2.892 billion [2]. - The capital flow data indicates that major stocks like Wu Yi Kang (603259) had a net inflow of 127 million from retail investors, despite a net outflow of 469 million from institutional investors [3]. - Other stocks such as Baihua Pharmaceutical (600721) and Hongbo Pharmaceutical (301230) also showed mixed capital flows, with varying degrees of net inflows and outflows from different investor types [3].
润达医疗:预计2025年度归属于上市公司股东的净利润为负值
Zhi Tong Cai Jing· 2026-01-16 08:10
润达医疗(603108)(603108.SH)发布公告,经公司财务部门初步核算,预计2025年年度归属于上市公 司股东的净利润为负值,公司2025年年度经营业绩将出现亏损。 ...
润达医疗(603108.SH):预计2025年度归属于上市公司股东的净利润为负值
智通财经网· 2026-01-16 08:10
智通财经APP讯,润达医疗(603108.SH)发布公告,经公司财务部门初步核算,预计2025年年度归属于 上市公司股东的净利润为负值,公司2025年年度经营业绩将出现亏损。 ...
朗玛信息(300288)1月16日主力资金净卖出1481.98万元
Sou Hu Cai Jing· 2026-01-16 08:03
Group 1 - The core viewpoint of the news is that Langma Information (300288) has experienced a significant decline in both revenue and net profit for the first three quarters of 2025, indicating potential challenges in its business operations [2] - As of January 16, 2026, Langma Information's stock closed at 15.0 yuan, down 3.97%, with a turnover rate of 6.91% and a trading volume of 177,300 hands, resulting in a transaction amount of 267 million yuan [1] - The net outflow of main funds on January 16 was 14.82 million yuan, accounting for 5.55% of the total transaction amount, while retail investors saw a net inflow of 9.07 million yuan, representing 3.4% of the total transaction amount [1] Group 2 - For the first three quarters of 2025, Langma Information reported a main operating income of 224 million yuan, a year-on-year decrease of 24.75%, and a net profit attributable to shareholders of 13.51 million yuan, down 67.04% year-on-year [2] - In Q3 2025, the company recorded a single-quarter main operating income of 72.53 million yuan, a decline of 36.46% year-on-year, and a net profit attributable to shareholders of -0.93 million yuan, reflecting a year-on-year decrease of 105.48% [2] - The company's debt ratio stands at 17.27%, with investment income of 16.99 million yuan and financial expenses of -2.53 million yuan, while the gross profit margin is reported at 29.25% [2]